Vor Biopharma Inc. (VOR)
$19.90+4.03%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $136M
- Beta
- 1.72
- P/E (TTM)
- -0.06
- Short % float
- 159.97%
- Days to cover
- 4.3
- SI change
- -1.1%
- 1W
- +6.47%
- 1M
- -10.92%
- vs SPY 1W
- +5.31%
- vs SPY 1M
- -13.91%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on VOR?
- LOPJLB’s latest quantitative signal on Vor Biopharma Inc. (VOR) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is VOR in?
- Vor Biopharma Inc. (VOR) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Vor Biopharma Inc. (VOR) do?
- Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature…